- 2,055
[EXTERNAL LINK] - White House to name first 10 drugs for Medicare negotiations early
Biden health officials are expected to reveal the initial list before the stock market opens Tuesday morning, because the impact on publicly traded companies that make any drugs on the list could affect their stock prices during trading. The White House is then set to tout the program on Tuesday afternoon.
Health officials have closely guarded the specific medicines that they plan to target for negotiation, though only a limited group of drugs appear to qualify under the program’s criteria.
“These drugs include blood thinners, diabetes medicines and cancer drugs,” Bailey Reavis, manager of federal relations at health advocacy group Families USA, said of the drugs that fit the parameters, which include pricey, widely used medicines without generic competitors. “We know that they’ll be drugs that cost Medicare billions of dollars annually.”
The lengthy timeline could also be complicated by no fewer than seven lawsuits filed in federal courts across the nation by the U.S. Chamber of Commerce and major drug companies, which contend that the negotiation program is unconstitutional.
Biden health officials are expected to reveal the initial list before the stock market opens Tuesday morning, because the impact on publicly traded companies that make any drugs on the list could affect their stock prices during trading. The White House is then set to tout the program on Tuesday afternoon.
Health officials have closely guarded the specific medicines that they plan to target for negotiation, though only a limited group of drugs appear to qualify under the program’s criteria.
“These drugs include blood thinners, diabetes medicines and cancer drugs,” Bailey Reavis, manager of federal relations at health advocacy group Families USA, said of the drugs that fit the parameters, which include pricey, widely used medicines without generic competitors. “We know that they’ll be drugs that cost Medicare billions of dollars annually.”
The lengthy timeline could also be complicated by no fewer than seven lawsuits filed in federal courts across the nation by the U.S. Chamber of Commerce and major drug companies, which contend that the negotiation program is unconstitutional.
